Found: 16
Select item for more details and to access through your institution.
Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30898-0
- By:
- Publication type:
- Article
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/pharmaceutics14071317
- By:
- Publication type:
- Article
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 3, p. 1, doi. 10.15252/emmm.202013180
- By:
- Publication type:
- Article
Intraductal patient‐derived xenografts of estrogen receptor α‐positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions.
- Published in:
- Journal of Pathology, 2019, v. 247, n. 3, p. 287, doi. 10.1002/path.5200
- By:
- Publication type:
- Article
Personalized Treatment of Advanced Non-small Cell Lung Cancer: EGFR Tyrosine Kinase Inhibitors as a Standard of Care.
- Published in:
- Journal of OncoPathology, 2013, v. 1, n. 4, p. 63, doi. 10.13032/tjop.2052-5931.100063
- By:
- Publication type:
- Article
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 316, doi. 10.3390/cancers15010316
- By:
- Publication type:
- Article
A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304573
- By:
- Publication type:
- Article
Peroxisome Proliferator-Activated Receptor Gamma and Regulations by the Ubiquitin-Proteasome Systemin Pancreatic Cancer.
- Published in:
- PPAR Research, 2012, p. 1, doi. 10.1155/2012/367450
- By:
- Publication type:
- Article
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-97
- By:
- Publication type:
- Article
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Hand and Foot Syndrome associated with docetaxel treatment.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 4, p. 554, doi. 10.3109/0284186X.2011.636755
- By:
- Publication type:
- Article
Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer.
- Published in:
- International Journal of Breast Cancer, 2013, p. 1, doi. 10.1155/2013/289563
- By:
- Publication type:
- Article
Oncology during the COVID-19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients.
- Published in:
- Oncology Letters, 2020, v. 20, n. 1, p. 441, doi. 10.3892/ol.2020.11599
- By:
- Publication type:
- Article
Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series.
- Published in:
- ISRN Otolaryngology, 2014, p. 1, doi. 10.1155/2014/289836
- By:
- Publication type:
- Article
Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series.
- Published in:
- ISRN Oncology, 2014, p. 1, doi. 10.1155/2014/289836
- By:
- Publication type:
- Article